CAPECCHI, PIER LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 15.758
EU - Europa 11.566
AS - Asia 5.771
SA - Sud America 1.038
Continente sconosciuto - Info sul continente non disponibili 413
AF - Africa 287
OC - Oceania 20
AN - Antartide 1
Totale 34.854
Nazione #
US - Stati Uniti d'America 15.470
GB - Regno Unito 2.517
CN - Cina 2.024
RU - Federazione Russa 2.012
IT - Italia 2.003
SG - Singapore 1.750
IE - Irlanda 1.322
BR - Brasile 868
SE - Svezia 830
DE - Germania 741
UA - Ucraina 698
FR - Francia 583
VN - Vietnam 547
HK - Hong Kong 454
FI - Finlandia 431
KR - Corea 264
IN - India 178
CA - Canada 152
BD - Bangladesh 130
ZA - Sudafrica 109
ES - Italia 80
TR - Turchia 76
NL - Olanda 66
MX - Messico 58
AR - Argentina 52
CI - Costa d'Avorio 45
IQ - Iraq 44
NG - Nigeria 44
JP - Giappone 43
BE - Belgio 42
PL - Polonia 41
PK - Pakistan 33
CZ - Repubblica Ceca 31
AT - Austria 29
EC - Ecuador 28
TH - Thailandia 28
CO - Colombia 27
LT - Lituania 25
VE - Venezuela 24
ID - Indonesia 21
AU - Australia 17
KE - Kenya 17
MA - Marocco 17
PH - Filippine 16
EG - Egitto 15
IR - Iran 15
CH - Svizzera 14
EE - Estonia 14
IL - Israele 14
JM - Giamaica 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
KZ - Kazakistan 13
TN - Tunisia 13
UZ - Uzbekistan 11
CR - Costa Rica 10
NP - Nepal 10
RO - Romania 10
GR - Grecia 9
JO - Giordania 9
TT - Trinidad e Tobago 9
BO - Bolivia 8
ET - Etiopia 8
OM - Oman 8
PE - Perù 8
PY - Paraguay 8
AL - Albania 7
CL - Cile 7
DZ - Algeria 7
EU - Europa 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
BG - Bulgaria 6
HR - Croazia 6
HU - Ungheria 6
LV - Lettonia 6
MY - Malesia 6
NI - Nicaragua 6
RS - Serbia 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
HN - Honduras 5
KG - Kirghizistan 5
MK - Macedonia 5
PR - Porto Rico 5
UY - Uruguay 5
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
LB - Libano 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
Totale 34.406
Città #
Southend 2.190
Dallas 1.614
Ashburn 1.476
Fairfield 1.433
Dublin 1.295
Singapore 975
San Jose 706
Chandler 691
Woodbridge 673
Santa Clara 629
Moscow 561
Jacksonville 559
Houston 550
Wilmington 536
Seattle 522
Milan 519
Beijing 502
Cambridge 465
Hong Kong 438
Siena 401
Ann Arbor 363
Menlo Park 358
Hefei 337
Council Bluffs 320
Seoul 259
Helsinki 253
Princeton 244
The Dalles 234
New York 226
Los Angeles 217
Nanjing 201
Rome 163
Ho Chi Minh City 150
Munich 147
Lauterbourg 138
Dong Ket 135
Boardman 125
Columbus 116
Dearborn 108
Hanoi 108
Florence 102
Johannesburg 101
Buffalo 96
San Diego 95
São Paulo 94
San Mateo 89
Nanchang 74
Shanghai 61
Turku 57
Brooklyn 55
Orem 55
Phoenix 54
Shenyang 54
Chicago 51
Toronto 51
Abidjan 45
San Francisco 45
Bengaluru 43
Düsseldorf 43
London 42
Abuja 39
Málaga 39
Brussels 38
Atlanta 37
Changsha 37
Nuremberg 36
Redondo Beach 33
Frankfurt am Main 32
Tianjin 32
Chennai 31
Guangzhou 31
Hebei 31
Tokyo 31
Turin 31
Warsaw 30
Boston 29
Denver 29
Montreal 29
Poggiomarino 29
Figino 28
Izmir 27
Kunming 27
Lancaster 26
Rio de Janeiro 26
Jiaxing 25
Lappeenranta 25
Washington 25
Jinan 24
Norwalk 23
Amsterdam 22
Da Nang 22
Mumbai 22
North Bergen 22
Poplar 22
Ankara 21
Falls Church 21
Stockholm 19
Bologna 18
Naples 18
Zhengzhou 18
Totale 23.349
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 437
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 434
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 423
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 422
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 414
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 412
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 411
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 388
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 382
Antirheumatic agents in covid-19: is IL-6 the right target? 376
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 375
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 357
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 355
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 351
Peripheral biomarkers' panel for severe COVID-19 patients 334
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 333
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 330
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis 328
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 317
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 316
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 312
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 311
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 307
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 305
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans 303
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 297
Allopurinol prevents ischaemia-dependent haemorheological changes 295
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 289
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation 287
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 287
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 275
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 271
Torsades de Pointes in patients with polymyalgia rheumatica 266
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 264
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 261
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 259
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 259
Serial KL-6 measurements in COVID-19 patients 259
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 254
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 253
Pleuroparenchymal fibroelastosis (PPFE) associated with giant cell arteritis: A coincidence or a novel phenotype? 253
Human rheumatoid synoviocytes express functional P2X7 receptors 251
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 250
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 250
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 250
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 250
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 249
Ultrasound measurement of rectus femoris muscle thickness as a quick screening test for sarcopenia assessment 249
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 248
Heart failure and chronic kidney disease in a registry of internal medicine wards 248
The role of P2X7 receptors in tissue fibrosis: a brief review 246
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 246
Statins and the joint: multiple targets for a global protection? 245
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 244
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 239
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 237
Connective tissue diseases and cardiac rhythm disorders: an overview 237
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 236
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 235
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients 228
Risk factors for hospital readmission of elderly patients 225
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 224
Early and delayed increase in plasma homocysteine levels in heart transplanted patients 223
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 222
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 217
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 216
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells 216
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 215
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 214
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 214
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 211
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 210
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 210
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 209
ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 207
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 207
Familial Mediterranean fever diagnosed in an elderly patient 206
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 205
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 203
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 203
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 202
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 202
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 202
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 202
Pathogenesis of the novel autoimmune-associated long-QT syndrome 201
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 200
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 200
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 196
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 196
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 195
Using Peripheral Blood Mononuclear Cells to determine proteome profiles in human end-stage chronic heart disease 194
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 192
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 190
Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: An in-vitro study in healthy humans. 188
Photopheresis immunomodulation after heart transplantation 187
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment 186
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 184
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 184
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 183
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 182
Totale 26.123
Categoria #
all - tutte 108.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.617 0 0 0 169 159 74 130 96 138 195 220 436
2022/20232.560 161 250 366 373 204 501 74 187 265 55 68 56
2023/20242.219 93 48 176 111 110 613 686 54 26 62 61 179
2024/20254.344 85 216 392 266 520 257 183 264 315 217 500 1.129
2025/202610.700 866 1.494 1.051 1.139 1.923 461 1.233 256 358 551 380 988
2026/20272.326 427 402 881 616 0 0 0 0 0 0 0 0
Totale 34.854